Top in GI: Endoscopic hemostasis system; FDA panel vote on C. difficile treatment
Click Here to Manage Email Alerts
The FDA recently cleared the endoscopic hemostasis system Nexpowder, which is intended to improve visibility and management of nonvariceal upper gastrointestinal bleeding, according to the manufacturer Medtronic.
Austin Chiang, MD, MPH, chief medical officer of gastrointestinal business at Medtronic, said in a company press release that the Nexpowder system “is a powerful tool for GI professionals to add to their toolboxes.” It was the top story in gastroenterology last week.
Another top story was about a fecal transplant therapy for recurrent Clostridioides difficile infection. An FDA panel recently voted in favor of the treatment, saying there is adequate data to support the safety and efficacy of it in adults.
Read these and more top stories in gastroenterology below:
Endoscopic hemostasis system cleared by FDA for nonvariceal upper GI bleeding
The FDA granted clearance to Medtronic’s endoscopic hemostasis system, Nexpowder, intended to improve visibility and management of upper gastrointestinal bleeding not linked to varices, according to a company press release. Read more.
FDA panel votes in favor of fecal transplant therapy for recurrent C. difficile infection
An FDA advisory committee recently voted there was adequate data to support the safety and efficacy of fecal microbiota transplant therapy Rebyota (RBX2660, Rebiotix Inc.) for the treatment of adult patients with recurrent C. difficile infection. Read more.
ACG, ASGE release first quality indicators for capsule endoscopy, deep enteroscopy
The American College of Gastroenterology and American Society for Gastrointestinal Endoscopy have released a joint guideline on comprehensive quality indicators for capsule endoscopy and deep enteroscopy in the diagnosis and management of small-bowel disease. Read more.
Colonoscopies with trainee involvement yield lower sessile serrated polyp detection rate
Sessile serrated polyp detection rate was the only quality metric reduced when trainees participated in colonoscopy, highlighting the importance of careful examination of the right colon when trainees are present, according to new data. Read more.
Men who have sex with men twice as likely to be diagnosed with IBD
Men who have sex with men were more than twice as likely to develop inflammatory bowel disease compared with men who have sex with women when engaging in “high-risk” sexual activity, according to research published in Gut. Read more.